Update on mild cognitive impairment

Current Neurology and Neuroscience Reports

Volumn 3, Issue 5, 2003, Pages 379-384

  Bennett, David A ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; GINKGO BILOBA EXTRACT; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ALZHEIMER DISEASE; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; MEMORY; MORBIDITY; MORTALITY; REVIEW; BRAIN; HOSPITALIZATION; METABOLISM; PATHOLOGY; RISK FACTOR;

BRAIN; CLINICAL TRIALS; COGNITION DISORDERS; DEMENTIA; HUMANS; NEUROTRANSMITTER AGENTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0642367012     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-003-0020-2     Document Type: Review

References (50)

1. Kral VA: Senescent forgetfulness: benign and malignant. Can Med Assoc J 1962, 86:257-260.
2. Crook T, Bartus RT, Ferris SH, et al.: Age-associated memory impairment: proposed diagnostic criteria and measures of clinical change. Dev Neuropsychol 1986, 2:261-276.
3. Jonker C, Hoyer C: The Amstel project: design and first findings. The course of mild cognitive impairment of the aged, a longitudinal 4-year study. Psychiatry J Univ Ott 1990, 15:207-211.
4. Flicker C, Ferris SH, Reisberg B: Mild cognitive impairment in the elderly: predictors of dementia. Neurology 1991, 41:1006-1009.
5. Petersen RC, Doody R, Kurz A, et al.: Current concepts in mild cognitive impairment. Arch Neurol 2001, 58:1985-1992.
6. Frisoni GB, Galluzzi S, Bresciani L, et al.: Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J Neurol 2002, 249:1423-1432.
7. Schneider JA, Wilson RS, Cochran EJ, et al.: Relation of cerebral infarctions to dementia and cognitive function in older person. Neurology 2003, 60:1082-1089.
8. Bennett DA, Wilson RS, Schneider JA, et al.: Natural history of mild cognitive impairment in older persons. Neurology 2002, 59:198-205.
9. Griffith HR, Belue K, Sicola A, et al.: Impaired financial abilities in mild cognitive impairment: a direct assessment approach. Neurology 2003, 60:449-457.
10. Meyer J, Xu G, Thornby J, et al.: Longitudinal analysis of abnormal domains comprising mild cognitive impairment (MCI) during aging. J Neurol Sci 2002, 201:19-25.
11. Mapstone M, Steffenella TM, Duffy CJ: A visuospatial variant of mild cognitive impairment: Getting lost between aging and AD. Neurology 2003, 60:802-808.
12. Storandt M, Grant EA, Miller JP, Morris JC: Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002, 59:1034-1041.
13. Wilson RS, Beckett LA, Barnes LL, et al.: Individual differences in rates of change in cognitive abilities of older persons. Psychol Aging 2002, 17:179-193.
14. Ritchie K, Artero S, Touchon J: Classification criteria for mild cognitive impairment: a population-based validation study. Neurology 2001, 56:37-42.
15. Darby D, Maruff P, Collie A, et al.: Mild cognitive impairment can be detected by multiple assessments in a single day. Neurology 2002, 59:1042-1046.
16. Larrieu S, Letenneur L, Orgogozo JM, et al.: Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002, 59:1594-1599.
17. Unverzagt FW, Gao S, Baiyewu O, et al.: Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging. Neurology 2001, 57:1655-1662.
18. Hanninen T, Hallikainen M, Tuomainen S, et al.: Prevalence of mild cognitive impairment: a population-based study in elderly subjects. Acta Neurol Scand 2002, 106:148-154.
19. Artero S, Touchon J, Ritchie K: Disability and mild cognitive impairment: a longitudinal population-based study. Int J Geriatr Psychiatry 2001, 16:1092-1097.
20. Lyketsos CG, Lopez O, Jones B, et al.: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002, 288:1475-1483.
21. DeCarli C, Miller BL, Swan GE, et al.: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001, 58:643-647.
22. Bennett DA, Wilson RS, Schneider JA, et al.: Apolipoprotein E4 allele, Alzheimer's disease pathology, and the clinical expression of Alzheimer's disease. Neurology 2003, 60:246-252.
23. DeKosky ST, Ikonomovic M, Styren S, et al.: Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann Neurol 2002, 51:145-155.
24. Mufson EJ, Chen EY, Cochran EJ, et al.: Entorhinal cortex b-amyloid load in individuals with mild cognitive impairment. Exp Neurol 1999, 158:469-490.
25. Mitchell TW, Mufson EJ, Schneider JA, et al.: Parahippocampal tau pathology in healthy aging, mild cognitive impairment and early Alzheimer's disease. Ann Neurol 2002, 51:182-189.
26. Ghoshal N, Garcia-Sierra F, Wuu J, et al.: Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease. Exp Neurol 2002, 177:475-493.
27. Kordower JH, Chu Y, Stebbins GT, et al.: Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol 2001, 49:202-213.
28. Morris JC, Storandt M, Miller JP, et al.: Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001, 58:397-405.
29. Mufson EJ, Ma SY, Cochran EJ, et al.: Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 2000, 427:19-30.
30. Mufson EJ, Ma SY, Dills J, et al.: Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2002, 443:136-153.
31. Chu YP, Cochran EJ, Bennett DA, et al.: Down regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2001, 437:296-307.
32. Ikonomovic MD, Mufson EJ, Wuu J, et al.: Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology. J Alzheimers Dis 2003, 5:39-48.
33. Mufson EJ, Ikonomovic MD, Styren SD, et al.: Preservation of brain nerve growth factor in the elderly with mild cognitive impairment. Arch Neurol 2003, in press.
34. Dickerson BC, Goncharova I, Sullivan MP, et al.: MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001, 22:747-754.
35. Du AT, Schuff N, Amend D, et al.: Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001, 71:441-447.
36. Kabani NJ, Sled JG, Chertkow H: Magnetization transfer ratio in mild cognitive impairment and dementia of Alzheimer's type. Neuroimage 2002, 15:604-610.
37. Van Der Flier WM, Van Den Heuvel DM, Weverling-Rijnsburger AW, et al.: Cognitive decline in AD and mild cognitive impairment is associated with global brain damage. Neurology 2002, 59:874-879.
38. Padovani A, Borroni B, Colciaghi F, et al.: Abnormalities in the pattern of platelet amyloid precursor protein forms in patients with mild cognitive impairment and Alzheimer disease. Arch Neurol 2002, 59:71-75.
39. Pratico D, Clark CM, Liun F, et al.: Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease. Arch Neurol 2002, 59:972-997.
40. Tabert MH, Albert SM, Borukhova-Milov L, et al.: Functional deficits in patients with mild cognitive impairment: prediction ofAD. Neurology 2002, 58:758-764.
41. Devanand DP, Michaels-Marston KS, Liu X, et al.: Olfactory deficits in patients with mild cognitive impairment predict Alzheimer's disease at follow-up. Am J Psychiatry 2000, 157:1399-1405.
42. Jack CR Jr, Petersen RC, Xu YC, et al.: Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology 1999, 52:1397-1403.
43. Arnaiz E, Jelic V, Almkvist O, et al.: Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001, 12:851-855.
44. Petersen RC, Smith GE, Ivnik RJ, et al.: Apolipoprotein E status as a predictor of the development of Alzheimer's disease in memory-impaired individuals. JAMA 1995, 273:1274-1278.
45. Riemenschneider M, Lautenschlager N, Wagenpfeil S, et al.: Cerebrospinal fluid tau and beta-amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment. Arch Neurol 2002, 59:1729-1734.
46. de Leon MJ, Segal S, Tarshish CY, et al.: Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairment. Neurosci Lett 2002, 333:183-186.
47. Okamura N, Arai H, Maruyama M, et al.: Combined analysis of CSF tau levels and [(123)I] iodoamphetamine SPECT in mild cognitive impairment: implications for a novel predictor of Alzheimer's disease. Am J Psychiatry 2002, 159:474-476.
48. Petersen RC, Stevens JC, Ganguli M, et al.: Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1133-1142.
49. Doody RS, Stevens JC, Beck C, et al.: Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001, 56:1154-1166.
50. Rapp S, Brenes G, Marsh AP: Memory enhancement training for older adults with mild cognitive impairment: a preliminary study. Aging Ment Health 2002, 6:5-11.